Key result
In patients requiring ECLS for AMI with cardiogenic shock, the 30-day survival rate was 38.9%, with preimplantation lactate, creatinine, and previous CPR predicting 30-day mortality.
Cohort (n=77)
No
In patients with AMI and cardiogenic shock treated with ECLS, 30-day survival is approximately 39%, with preimplantation lactate, creatinine, and prior CPR serving as independent predictors of mortality.
No takes yet. Share an insight, caveat, or question.
May aid pre-ECLS risk stratification in AMI shock; leaves open optimal patient selection.
Demondion et al. (2013) conducted a cohort in Acute myocardial infarction with cardiogenic shock (n=77). Extracorporeal life support (ECLS) was evaluated on 30-day mortality. In patients requiring ECLS for AMI with cardiogenic shock, the 30-day survival rate was 38.9%, with preimplantation lactate, creatinine, and previous CPR predicting 30-day mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: